Introduction
xerostomia, Head and neck cancers, Xerostomia, HNC, Cancer
XEROSTOMIA, XEROSTOMIA, ADVERSE EFFECTS, SECONDARY, HEAD AND NECK CANCER, CANCER
Head and neck cancers (HNC) have a reported incidence of more than 900,000 new cases per year [RT-induced xerostomia (RIX) is one of the most common adverse effects of RT in patients with HNC and a major determinant of survivors’ quality of life (QoL) [The above-mentioned agent has already been tested in retrospective and prospective clinical trials [The primary objective of this RCT was to evaluate the reduction of patients’ xerostomia symptoms due to RT through a modified version of the Xerostomia Questionnaire (XQ) [The secondary objectives of this study were (1) to evaluate the improvement in QoL, evaluated through the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-H&N35 questionnaires [